Manufacturer record

Healthy Life Pharma Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

8 batches manufactured by Healthy Life Pharma Pvt. Ltd (Maharashtra) were declared Not of Standard Quality between November 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

8 records linked to Healthy Life Pharma Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
8Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Nov 2019 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

8
NSQ batches since 2019
8
Products affected
Assay
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2019 · 12020 · 12023 · 12025 · 12026 · 4

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Bisacodyl Tablets IP 5mg 8676Mfg 2026-03 · Exp 2029-02 The sample does not conform to I.P. w.r.to the tests for AssayAssay SDTL,GuwahatiState lab Jul 2026
Vitamin B1 Vitamin B6 Vitamin B2 Niacinamide Calcium D Pentothenate 10512Mfg 2025-02 · Exp 2027-01 Vitamin B1 & for reason stated under descriptionDescription SDT&RL, BhubaneswarState lab Jun 2026
Thyroxine Sodium Tablets IP 50mcg 1030Mfg 2025-04 · Exp 2027-03 The sample does not conform to I.P with respect to the " Assay, Dissolution and Uniformity of content of Thyroxine Sodium equivalent to anhydrous Thyroxine Sodium.Assay CDTL, IndoreCDSCO lab May 2026
Multivitamin Tablets N.F.I. 23448Mfg 2024-11 · Exp 2026-10 The sample does not confirm to the claim with respect to Assay of vitamin D3 (Nil).Assay DTL JaipurState lab Jan 2026
Calcium And Vitamin D3 Tablets IP 7493Mfg 2024-01 · Exp 2025-12 Assay/Content of Vitamin D3Assay RDTL, GuwahatiCDSCO lab Mar 2025
PYRAZINAMIDE TABLETS I.P. 500 mg (PYRIZ-500) 10734Mfg 2023-03 · Exp 2025-08 DissolutionDissolution RDTL GuwahatiState lab Nov 2023
(ALBENDAZOLE TABLETS IP 400 MG) 3285Mfg 2019-12 · Exp 2021-11 DissolutionDissolution RDTL ChandigarhCDSCO lab Jul 2020
Zinc Sulphate Tablets IP 20 mg 5069Mfg 2019-06 · Exp 2021-05 Disintegration and Uniformity of DispersionDisintegration CDTL MumbaiCDSCO lab Nov 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.